Insider Transactions Reported by 21 Insiders of Esperion Therapeutics, Inc.

Symbol
ESPR on Nasdaq
Location
Ann Arbor, MI

Insiders trading volume in the past year

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sheldon L. Koenig President and CEO, Director $6,621,326 -$309,873 -4.5% 17 Dec 2025
BIOTECH TARGET N V 10%+ Owner $5,575,065 24 May 2021
Benjamin Halladay Chief Financial Officer $2,059,474 -$60,321 -2.8% 17 Dec 2025
Benjamin Looker General Counsel $1,740,733 -$53,614 -3% 17 Dec 2025
John B. Harlow Jr. Chief Commercial Officer $1,566,537 04 Dec 2025
Joanne M. Foody Chief Medical Officer $1,033,168 17 Jul 2024
Eric Warren Chief Commercial Officer $671,493 -$4,448 -0.66% 17 Apr 2025
Richard Bartram Chief Financial Officer $360,605 14 Mar 2022
Alan Fuhrman Director $185,252 23 May 2024
GOTTO ANTONIO M JR MD D PHIL Director $180,770 23 May 2024
J. MARTIN CARROLL Director $130,770 29 May 2025
Jay Shepard Director $120,329 29 May 2025
STEPHEN ROCAMBOLI Director $108,058 29 May 2025
Tracy M. Woody Director $105,300 29 May 2025
NICOLE VITULLO Director $105,300 29 May 2025
H. Fischer Seth Director $101,570 29 May 2025
Robert E. Hoffman Director $69,024 29 May 2025
Jeffrey Berkowitz Director $61,594 26 May 2022
DANIEL JANNEY Director $59,777 27 May 2021
MARK E. MCGOVERN Director $35,419 27 May 2021
JOHN CRAIG THOMPSON Director 01 Jul 2025

Recent Insider Transactions by Companies or Individuals for Esperion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.